Patents by Inventor Andrew G. Buchanan

Andrew G. Buchanan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10077305
    Abstract: The present invention provides antibodies and antigen-binding fragments that specifically bind PD-1 (Programmed Death 1), thereby modulating immune responses in general, and those mediated by TcR and CD28, in particular. The disclosed compositions and methods may be used for example, in treating autoimmune diseases, inflammatory disorders, allergies, transplant rejection, cancer and other immune system disorders.
    Type: Grant
    Filed: September 9, 2014
    Date of Patent: September 18, 2018
    Assignee: MedImmune Limited
    Inventors: Andrew G. Buchanan, Ross Stewart, Mathieu Chodorge